Dyadic International (DYAI) Current Deferred Revenue (2018 - 2026)
Dyadic International (DYAI) reported Current Deferred Revenue of $1.11 million for Q1 2026, up 66.9% from $665,216 a year earlier but down 35.8% from the prior quarter.
Powered by 
Analysis
Dyadic International (DYAI) Current Deferred Revenue (2018 - 2026) Analysis & Trends
At the end of FY2025, Dyadic International posted Current Deferred Revenue of $1.73 million, up 107.6% from FY2024.
- Current Deferred Revenue has a five-year compound annual growth rate of 69.7% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $833,813 in FY2024 (+70.1%), $490,113 in FY2023, $40,743 in FY2022 (-73.0%) and $151,147 in FY2021 (+22.9%).
- Five-year quarterly Current Deferred Revenue spans a low of $9,000 in Q2 2023 and a high of $315.01 million in Q1 2022.
- Year over year, Current Deferred Revenue has now increased in each of the last six quarters, with growth averaging 118.2% over the last six quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q1 2024 (growth of 719.0%); the low point was Q1 2023 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $1.73 million (Q4 2025), $1.34 million (Q3 2025) and $1.83 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Dyadic International | 16.03 Mn | 9.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 665,216.00 |
| Dec 31, 2024 | 833,813.00 |
| Sep 30, 2024 | 514,483.00 |
| Jun 30, 2024 | 482,323.00 |
| Mar 31, 2024 | 534,018.00 |
| Dec 31, 2023 | 490,113.00 |
| Sep 30, 2023 | 13,897.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | 65,207.00 |
| Dec 31, 2022 | 40,743.00 |
| Sep 30, 2022 | 445,044.00 |
| Jun 30, 2022 | 901,331.00 |
| Mar 31, 2022 | 315.01 Mn |
| Dec 31, 2021 | 151,147.00 |
| Sep 30, 2021 | 162,680.00 |
| Jun 30, 2021 | 258,748.00 |
API Access
Dyadic International Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DYAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "DYAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=DYAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();